-transparent.png){kind=logo}
Angio-immunoblastic lymphadenopathy is a systemic disease of unknown aetiology. It carries a high mortality mainly from infection which results both from the intrinsic immunodeficiency and its exacerbation by treatment with steroids and or cytotoxics. We report a case of angio-immunoblastic lymphadenopathy with the unusual feature of hypogammaglobulinaemia who died of miliary tuberculosis. We suggest that all patients with angio-immunoblastic lymphadenopathy who have inactive tuberculous foci should be given antituberculous prophylaxis.
Related Publications
S Hatty, and
G J Mufti, and
T J Hamblin
July 1993,
Nederlands tijdschrift voor geneeskunde,
S Hatty, and
G J Mufti, and
T J Hamblin
August 1982,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
S Hatty, and
G J Mufti, and
T J Hamblin
April 1977,
Harefuah,
S Hatty, and
G J Mufti, and
T J Hamblin
March 1978,
Schweizerische medizinische Wochenschrift,
S Hatty, and
G J Mufti, and
T J Hamblin
September 1978,
Deutsche medizinische Wochenschrift (1946),
S Hatty, and
G J Mufti, and
T J Hamblin
January 1979,
Acta clinica Belgica,
S Hatty, and
G J Mufti, and
T J Hamblin
November 1986,
Harefuah,
S Hatty, and
G J Mufti, and
T J Hamblin
January 1975,
The New England journal of medicine,
S Hatty, and
G J Mufti, and
T J Hamblin
June 1974,
Lancet (London, England),
S Hatty, and
G J Mufti, and
T J Hamblin
August 1979,
Lancet (London, England),
